FDA Approves Moderna's First mRNA Flu Shot

BioXconomy · health

The US Food and Drug Administration (FDA) has approved Moderna's mRNA vaccine against seasonal influenza, known as mRNA-1010 or mFLUSIVA. This marks a significant milestone as it is the first vaccine of its kind to receive approval for flu protection. The development signifies a new era in vaccine technology, leveraging messenger RNA (mRNA) for influenza prevention.